Orion Pushing Ahead In Prostate Cancer, R&D Reorganized

Extending Nubeqa's Indications

 
• By John Davis

Finland’s Orion Corporation is highlighting its prostate cancer and other oncology candidates in its reorganized R&D.

Espoo, Finland
Espoo, Finland, Where Orion Corp Is Headquartered • Source: Shutterstock

More from Anticancer

More from Therapy Areas